These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 1933287)

  • 1. Brain-derived cells contain a specific binding site for Gp120 which is not the CD4 antigen.
    Kozlowski MR; Sandler P; Lin PF; Watson A
    Brain Res; 1991 Jul; 553(2):300-4. PubMed ID: 1933287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
    Hart TK; Kirsh R; Ellens H; Sweet RW; Lambert DM; Petteway SR; Leary J; Bugelski PJ
    Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2189-93. PubMed ID: 2006155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding.
    Healey D; Dianda L; Moore JP; McDougal JS; Moore MJ; Estess P; Buck D; Kwong PD; Beverley PC; Sattentau QJ
    J Exp Med; 1990 Oct; 172(4):1233-42. PubMed ID: 1698911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell line.
    Harouse JM; Collman RG; González-Scarano F
    J Virol; 1995 Dec; 69(12):7383-90. PubMed ID: 7494242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5.
    Raja A; Venturi M; Kwong P; Sodroski J
    J Virol; 2003 Jan; 77(1):713-8. PubMed ID: 12477875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope protein gp120 on human fetal astrocytes.
    Ma M; Geiger JD; Nath A
    J Virol; 1994 Oct; 68(10):6824-8. PubMed ID: 8084022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies.
    Kaiser PK; Offermann JT; Lipton SA
    Neurology; 1990 Nov; 40(11):1757-61. PubMed ID: 2234433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.
    Hoffman TL; LaBranche CC; Zhang W; Canziani G; Robinson J; Chaiken I; Hoxie JA; Doms RW
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6359-64. PubMed ID: 10339592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Trials Network.
    Montefiori DC; Graham BS; Zhou J; Zhou J; Bucco RA; Schwartz DH; Cavacini LA; Posner MR
    J Clin Invest; 1993 Aug; 92(2):840-7. PubMed ID: 8349820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120.
    Hioe CE; Tuen M; Chien PC; Jones G; Ratto-Kim S; Norris PJ; Moretto WJ; Nixon DF; Gorny MK; Zolla-Pazner S
    J Virol; 2001 Nov; 75(22):10950-7. PubMed ID: 11602735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
    Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
    J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
    Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
    J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short synthetic peptides derived from viral proteins compete with HIV gp120 for the binding to CD4 receptors.
    Chersi A; Pugliese O; Federico A; Viora M
    Viral Immunol; 2000; 13(4):547-54. PubMed ID: 11192301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competition of HLA-DR and a beta 2 domain peptide for HIV envelope glycoprotein gp120 binding to CD4.
    Autiero M; Houlgatte R; Martin M; Auffray C; Guardiola J; Piatier-Tonneau D
    Int Immunol; 1995 Feb; 7(2):191-7. PubMed ID: 7734415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jacalin, a lectin with anti-HIV-1 properties, and HIV-1 gp120 envelope protein interact with distinct regions of the CD4 molecule.
    Corbeau P; Haran M; Binz H; Devaux C
    Mol Immunol; 1994 Jun; 31(8):569-75. PubMed ID: 8196669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 peptide-protein conjugates, but not recombinant human CD4, bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients.
    Ghetie V; Slaughter C; Wheeler HT; Uhr JW; Vitetta ES
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5690-3. PubMed ID: 2062847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus-infected monocyte-derived macrophages express surface gp120 and fuse with CD4 lymphoid cells in vitro: a possible mechanism of T lymphocyte depletion in vivo.
    Crowe SM; Mills J; Elbeik T; Lifson JD; Kosek J; Marshall JA; Engleman EG; McGrath MS
    Clin Immunol Immunopathol; 1992 Nov; 65(2):143-51. PubMed ID: 1356673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase.
    Schneider-Schaulies J; Schneider-Schaulies S; Brinkmann R; Tas P; Halbrügge M; Walter U; Holmes HC; Ter Meulen V
    Virology; 1992 Dec; 191(2):765-72. PubMed ID: 1360181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for inhibitors of HIV gp120-CD4 binding using an enzyme-linked immunoabsorbent assay.
    Gilbert M; Brigido L; Müller WE; Hansen JE; Ezekowitz RA; Mills J
    J Virol Methods; 1993 Apr; 42(1):1-12. PubMed ID: 8100569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.